Neuronetics, Inc.
STIM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001227636
In the last 90 days, Neuronetics, Inc. insiders filed 2 open-market purchases and 0 sales; 86 institutions reported holding it in 13F filings for Q2 2026, worth $48.4M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Neuronetics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +22 vs. Q1 2021
- Shares held
- 23.3M
- +2.59M (+12.5%) vs. Q1 2021
- Total value
- $373.7M
- +$117.3M (+45.7%) vs. Q1 2021
- New holders
- 33
- 35 more added
- Sold out
- 11
- 24 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $48.4M |
| Q1 2026 | 99 | $60.4M |
| Q4 2025 | 95 | $58.3M |
| Q3 2025 | 99 | $57.8M |
| Q2 2025 | 90 | $63.1M |
| Q1 2025 | 102 | $63.2M |
| Q4 2024 | 45 | $12.2M |
| Q3 2024 | 48 | $8.05M |
| Q2 2024 | 67 | $31.5M |
| Q1 2024 | 66 | $84.2M |
| Q4 2023 | 66 | $46.2M |
| Q3 2023 | 56 | $23.4M |
| Q2 2023 | 69 | $38.6M |
| Q1 2023 | 74 | $53.6M |
| Q4 2022 | 82 | $120.4M |
| Q3 2022 | 76 | $54.4M |
| Q2 2022 | 77 | $56.4M |
| Q1 2022 | 83 | $59.9M |
| Q4 2021 | 80 | $89.0M |
| Q3 2021 | 97 | $139.9M |
| Q2 2021 | 105 | $373.7M |
| Q1 2021 | 83 | $256.4M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Neuronetics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 420 | $6.00K | 0.00% | −2,236−84.2% | Reduced |
| Captrust Financial Advisors | 347 | $6.00K | 0.00% | −6−1.7% | Reduced |
| Cutler Group LP | 400 | $6.00K | 0.00% | +400 | New |
| FormulaFolio Investments, LLC | 213 | $3.00K | 0.00% | 00.0% | Unchanged |
| O'Shaughnessy Asset Management, LLC | 124 | $2.00K | 0.00% | −37−23.0% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −919,000−100.0% | Sold out |
| Interwest Venture Management Co | 0 | $0 | 0.00% | −497,158−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −90,912−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −66,839−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −58,263−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −48,806−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −18,908−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −10,922−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −2,221−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −388−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −53−100.0% | Sold out |